[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"dialysis-related-complication\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:dialysis-related-complication":33},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,52,75],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":35,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":51},"100602469","studies-on-adsorption-international-learning-initiative-global-100602469",false,"NCT07123909","Studies on Adsorption International Learning Initiative Global","The Use of Sorption Technologies in Patients Receiving Program Hemodialysis With Inflammatory Syndrome","SAILING","Inclusion Criteria:\n\n1. Adequate dialysis defined by a KT\u002FV index ≥ 1.4\n2. No active inflammatory process or infection\n3. Age ≥ 18 years\n4. Receiving standard hemodialysis regimen three times weekly, at least 4 hours per session\n5. Participants with elevated interleukin-6 (IL-6) and\u002For C-reactive protein (CRP) levels exceeding local laboratory reference values\n\nExclusion Criteria:\n\n1. Current use of steroids or immunosuppressive therapy\n2. History of kidney transplantation\n3. Diagnosis of cancer\n4. Pregnancy","ALL","18 Years",{"count":20,"type":21},60,"ESTIMATED","INTERVENTIONAL",[24],"NA","Use of sorption technologies in patients undergoing maintenance hemodialysis with inflammatory syndrome and clinical manifestations of uremia",[27,28,29,30,31,32,33,34],"CKD (Chronic Kidney Disease) Stage 5D","Uremia; Chronic","Uremic; Toxemia","Inflammation Chronic","Hemodialysis","Inflammation Biomarkers","Dialysis Related Complication","Anemia Associated With End Stage Renal Disease",[36,37,38],"Program dialysis","Sorption","Complications of program dialysis","RECRUITING","2025-12-03",{"date":42,"type":43},"2025-12-10","ACTUAL",{"date":45,"type":43},"2025-06-01",{"date":47,"type":21},"2026-06-30",{"name":49,"class":50},"Botkin Hospital","OTHER",1,{"id":53,"slug":54,"hasResults":11,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":4,"eligibilityCriteria":58,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":59,"enrollmentInfo":60,"targetDuration":4,"studyType":22,"phases":62,"briefSummary":63,"conditions":64,"keywords":4,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":4},"100590031","how-to-prevent-complications-during-dialysis-100590031","NCT06962124","How to Prevent Complications During Dialysis","The Effect of Accurate Measurement of Dry Weight Based on pre_dialysis Serum Sodium Measurement on Reduction of Hemodialysis Complications","Inclusion Criteria:\n\n\\- 6- not dependent to mechanical ventilation\n\n1. at least one year history of hemodialysis\n2. adults aged 18 to 65 years old\n3. ability to communicate verbally\n4. with no history of diabetes mellitus, urinary incontinence syndrome, heart and liver failure, and adrenal hypertrophy 5 -no use of antihypertensive and antispasmodic drugs four hours before dialysis\n\nExclusion Criteria:\n\n1- Impaired consciousness 2- participant's withdrawal from the study 5-death 3- severe blood supply problem in the fistula or vascular access 4-migration or travel during the study\n\n\\-","65 Years",{"count":61,"type":21},50,[24],"We aimed to determine the effect of accurate assessment of dry weight based on measuring blood sodium level before dialysis to evaluate the effect of adjustment of ultrafiltration rate on hemodialysis complications and take a step forward to improve patient care and the quality of hemodialysis.",[33],"NOT_YET_RECRUITING","2025-04-29",{"date":68,"type":43},"2025-05-08",{"date":70,"type":21},"2025-10-01",{"date":72,"type":21},"2025-12-01",{"name":74,"class":50},"Assiut University",{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":82,"targetDuration":4,"studyType":22,"phases":84,"briefSummary":85,"conditions":86,"keywords":89,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":51},"100534054","multi-center-clinical-study-on-hemoperfusion-of-kha80-100534054","NCT06233838","Multi-center Clinical Study on Hemoperfusion of KHA80","Prospective, Multicenter, Randomized, Open Label Study on the Efficacy and Safety of Comparison of KHA80 Blood Perfusion Combined With Hemodialysis and Conventional Hemodialysis in Clearing IL-6, β2-MG and PTH in Maintenance Hemodialysis Patients","Inclusion Criteria:\n\n1. Age ≥18 years old, regardless of sex;\n2. According to the 2012 KDIGO guidelines, it was diagnosed as CKD5 (EGFR ≦ 15ml\u002F(min ˙ 1.73m2));\n3. receive regular hemodialysis (including hemodialysis filtration) for 4 hours twice a week for ≧3 months;\n4. blood β 2-mg ≥ 30 mg\u002FL and\u002For PTH ≥ 600 pg\u002FmL and\u002For IL-6 ≥ 16.2 pg\u002FmL;\n5. Sign the informed consent form.\n\nExclusion Criteria:\n\n1. Those who are known to have allergic reactions, contraindications or intolerance to the materials of dialyzers and hemoperfutors;\n2. Patients with severe bleeding tendency and active bleeding, or with definite coagulation dysfunction, with a platelet count of \\\u003C 60× 109\u002FL;\n3. Hemodialysis blood flow \\\u003C 200 ml\u002Fmin.\n4. Kt\u002FV\\\u003C1.2；\n5. Serum albumin \\\u003C 30g\u002FL;\n6. Parathyroid resection within one year;\n7. people with low blood pressure and severe cardiopulmonary insufficiency;\n8. lactating or pregnant women or those who plan to be pregnant within one year;\n9. infection, history of malignant tumor, active stage of rheumatic immune disease;\n10. Patients whose life expectancy is less than one year;\n11. Other clinical researchers are currently or recently (within 30 days);\n12. According to the researcher's judgment, the patient has other unsuitable conditions.",{"count":83,"type":21},394,[24],"To evaluate the decreasing rate of blood IL-6, β2-MG and PTH in maintenance hemodialysis patients in the 52nd week compared with routine hemodialysis.",[87,88,33],"Uremia","Uremic Osteodystrophy",[90,91,92,93,94],"KHA80","Maintenance hemodialysis","IL-6","β2-MG","PTH","2025-01-10",{"date":97,"type":43},"2025-01-14",{"date":99,"type":21},"2025-01-13",{"date":101,"type":21},"2027-05-31",{"name":103,"class":50},"First Affiliated Hospital of Fujian Medical University"]